Logo image of CARM

CARISMA THERAPEUTICS INC (CARM) Stock Income Statement

USA - NASDAQ:CARM - US14216R1014 - Common Stock

0.1539 USD
-0.12 (-43.81%)
Last: 10/10/2025, 9:13:56 PM
0.1181 USD
-0.04 (-23.26%)
After Hours: 10/10/2025, 9:13:56 PM

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2025-6-30)
2024
(2024-12-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
Revenue
CARM Revenue ChartCARM Revenue over time chart
10.77M19.63M14.92M40.00M26.54M
Gross Premiums Earned
CARM Gross Premiums Earned ChartCARM Gross Premiums Earned over time chart
nullnullnullnullnull
Loss Claims
CARM Loss Claims ChartCARM Loss Claims over time chart
nullnullnullnullnull
Deferred Policy Acquisition Expense
CARM Deferred Policy Acquisition Expense ChartCARM Deferred Policy Acquisition Expense over time chart
nullnullnullnullnull
Net Interest Income
CARM Net Interest Income ChartCARM Net Interest Income over time chart
nullnullnullnullnull
Non Interest Income
CARM Non Interest Income ChartCARM Non Interest Income over time chart
nullnullnullnullnull
Loan Loss Provision
CARM Loan Loss Provision ChartCARM Loan Loss Provision over time chart
nullnullnullnullnull
Net Interest Income after Provision
CARM Net Interest Income after Provision ChartCARM Net Interest Income after Provision over time chart
nullnullnullnullnull
Non Interest Expense
CARM Non Interest Expense ChartCARM Non Interest Expense over time chart
nullnullnullnullnull
Minority Interest Expense
CARM Minority Interest Expense ChartCARM Minority Interest Expense over time chart
nullnullnullnullnull
Cost Of Goods
CARM Cost Of Goods ChartCARM Cost Of Goods over time chart
nullnullnullnullnull
Gross Profit
CARM Gross Profit ChartCARM Gross Profit over time chart
nullnullnullnullnull
Operating Expenses
CARM Operating Expenses ChartCARM Operating Expenses over time chart
56.88M81.81M103.65M26.38M-2.14M
Research and Development
CARM Research and Development ChartCARM Research and Development over time chart
38.48M59.67M74.13M38.59M25.31M
Selling, General, and Administrative Expenses
CARM Selling, General, and Administrative Expenses ChartCARM Selling, General, and Administrative Expenses over time chart
18.39M22.14M29.52M39.79M29.39M
Operating Income
CARM Operating Income ChartCARM Operating Income over time chart
-46.11M-62.18M-88.73M13.62M28.68M
Interest Income/Expense
CARM Interest Income/Expense ChartCARM Interest Income/Expense over time chart
-1.12M1.70M1.85M1.85Mnull
Other Income/Expense
CARM Other Income/Expense ChartCARM Other Income/Expense over time chart
nullnullnull300.00K-60.00K
Non Recurring Items
CARM Non Recurring Items ChartCARM Non Recurring Items over time chart
nullnullnull-39.53M-37.23M
Income Before Taxes
CARM Income Before Taxes ChartCARM Income Before Taxes over time chart
-49.38M-60.48M-86.88M-23.76M-8.61M
Income Tax
CARM Income Tax ChartCARM Income Tax over time chart
nullnullnull-3.88M-8.27M
Net Income
CARM Net Income ChartCARM Net Income over time chart
-49.38M-60.48M-86.88M-19.88M-340.00K
EBITDA
CARM EBITDA ChartCARM EBITDA over time chart
null-58.83M-85.89M13.63M28.77M
 
Per Share Data
EPS Diluted Total Ops
CARM EPS Diluted Total Ops ChartCARM EPS Diluted Total Ops over time chart
-1.1835-1.4588-2.5915-1.98-0.04
Non GAAP EPS
CARM Non GAAP EPS ChartCARM Non GAAP EPS over time chart
-1.18-1.46-3.4699999999999998-20.6600000000000003
 
Statistics
Profit Margin
CARM Profit Margin ChartCARM Profit Margin over time chart
-458.60%-308.05%-582.34%-49.70%-1.28%
Operating Profit Margin
CARM Operating Profit Margin ChartCARM Operating Profit Margin over time chart
-428.26%-316.72%-594.75%34.05%108.06%

All data in USD

Charts

CARM Income Statement data chartCARM Revenue, Operating Income, Net Income and EBITDA ChartIncome Statements 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM 0 -50M -100M
CARM Earnings Per Share (EPS) chartCARM EPS Diluted and non-GAAP ChartEarnings Per Share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM 0 -10 -20 -30